Clinical Trial

A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This clinical study is a retrospective, observational, and multicenter post marketing real-world study aimed at evaluating the efficacy and safety of CNCT-19 in the treatment of Chinese adult B-cell acute lymphoblastic leukemia patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-25.
Trial Details
NCT Number NCT07269587
Lead Sponsor Ruijin Hospital
Conditions ALL (Acute B-Lymphoblastic Leukemia), CAR-T Cell Therapy
Enrollment 275 participants
Start Date 2025-11-07
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-10